Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis

Canadian Journal of Psychiatry

Volumn 54, Issue 10, 2009, Pages 710-718

  Álvarez Jiménez, Mario ^a,b   Gleeson, John F ^c   Cotton, Sue ^c   Wade, Darryl ^c   Gee, Donna ^a   Pearce, Tracey ^a   Crisp, Kingsley ^a   Spiliotacopoulos, Daniela ^c   Newman, Belinda ^c   McGorry, Patrick D ^c  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adherence; Cognitive behavioural therapy; Duration of untreated psychosis; First episode psychosis; Insight; Staging model

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INTROSPECTION; JUVENILE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SINGLE BLIND PROCEDURE; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; THERAPY DELAY;

EID: 70350501245     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370905401008     Document Type: Article

References (59)

1. Jackson HJ, McGorry PD, Killackey E, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: the ACE project. Psychol Med. 2007;16:1-11.
2. Lewis S, Tarrier N, Haddock G, et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry Suppl. 2002;43:91-97. (Pubitemid 34983519)
3. Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172(33):53-59. (Pubitemid 28258899)
4. Penn DL, Waldheter EJ, Perkins DO, et al. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry. 2005;162(12):2220-2232. (Pubitemid 41740199)
5. Haddock G, Lewis S, Bentall R, et al. Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatry. 2006;188:250-254. (Pubitemid 43341653)
6. World Health Organization. Adherence to long term therapy: evidence for action. Geneva (CH): WHO; 2003.
7. Haynes RB, Yao X, Degani A, et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005(4):CD000011.
8. Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry. 1996;169(4):444-450. (Pubitemid 126735799)
9. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry. 2002;63(12):1121-1128.
10. Perkins DO, Johnson JL, Hamer RM, et al. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res. 2006;83(1):53-63.
11. Awad AG, Voruganti LN. New antipsychotics, compliance, quality of life, and subjective tolerability - are patients better off? Can J Psychiatry. 2004;49(5):297-302.
12. Johnson DP, Penn DL, Bauer DJ, et al. Predictors of the therapeutic alliance in group therapy for individuals with treatment-resistant auditory hallucinations. Br J Clin Psychol. 2008;47(2):171-183.
13. Startup M, Jackson MC, Startup S. Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. J Nerv Ment Dis. 2006;194(10):740-745. (Pubitemid 44581100)
14. Gleeson J, Cotton SM, Alvarez-Jimenez M, et al. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry. 2009;70(4):477-486.
15. Gleeson J, Wade D, Castle D, et al. The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: rationale and sample characteristics. J Ment Health. 2008;17(1):19-32. (Pubitemid 351238475)
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
17. Overall JE, Gorham DR. The brief psychiatric rating-scale. Psychol Rep. 1962;10(3):799-812.
18. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand. 2006;114(2):109-117. (Pubitemid 44034269)
19. Ryle A, Kerr IB. Cognitive analytic therapy. Br J Psychiatry. 2003;183:79.
20. Early Psychosis Prevention and Intervention Centre (EPPIC). Case management in early psychosis: a handbook. Melbourne (AU): EPPIC; 2001.
21. Alvarez-Jimenez M, Wade D, Cotton S, et al. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive behavioural therapy for relapse prevention in first-episode psychosis. Aust N Z J Psychiatry. 2008;42(12):1013-1020.
22. Falloon IR, editor. Handbook of behavioral family therapy. New York (NY): Guilford Press; 1988.
23. Mueser KT, Glynn SM. Behavioral family therapy for psychiatric disorders. Oakland (CA): New Harbinger; 1999.
24. Linszen DH, Dingemans P, Van Der Does JW, et al. Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychol Med. 1996;26:333-342. (Pubitemid 26075206)
25. Tait L, Birchwood M, Trower P. Predicting engagement with services for psychosis: insight, symptoms and recovery style. Br J Psychiatry. 2003;182:123-128. (Pubitemid 36177234)
26. Rettenbacher MA, Hofer A, Eder U, et al. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry. 2004;65(9):1211-1218.
27. Ayuso-Mateos JL, Pereda A, Dunn G, et al. Predictors of compliance with psychological interventions offered in the community. Psychol Med. 2007;37(5):717-725. (Pubitemid 46511096)
28. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry. 2007;164(6):859-860.
29. McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry. 2006;40(8):616-622.
30. Norman RM, Malla AK, Manchanda R. Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis. Schizophr Res. 2007;95(1-3):111-114. (Pubitemid 47313646)
31. Verdoux H, Liraud F, Bergey C, et al. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr Res. 2001;49(3):231-241. (Pubitemid 32453224)
32. Kuipers E, Bebbington P, Dunn G, et al. Influence of carer expressed emotion and affect on relapse in non-affective psychosis. Br J Psychiatry. 2006;188:173-179. (Pubitemid 43171075)
33. Cannon-spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-484.
34. Amador XF, Flaum M, Andreasen NC, et al. Awareness of illness in schizophrenia, schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51(10):826-836. (Pubitemid 24313308)
35. Montgomery SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol. 1979;3:429-433.
36. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12(4):578-593.
37. Andreasen NC. Scale for Assessment of Negative Symptoms (SANS). Iowa City (IA): University of Iowa; 1984.
38. Goldman HH, Skodol AE, Lave TR. Revising Axis-V for DSM-IV - a review of measures of social functioning. Am J Psychiatry. 1992;149(9):1148-1156.
39. Wiedemann G, Rayki O, Feinstein E, et al. The Family Questionnaire: development and validation of a new self-report scale for assessing expressed emotion. Psychiatry Res. 2002;109(3):265-279. (Pubitemid 34311983)
40. Goldberg DP. The detection of psychiatric illness by questionnaire: a technique for the identification and assessment of non-psychotic psychiatric illness. London (GB): Oxford University Press (Maudsley Monograph no 21); 1972.
41. Szmukler GI, Burgess P, Herrman H, et al. Caring for relatives with serious mental illness: the development of the experience of caregiving inventory. Soc Psychiatry Psychiatr Epidemiol. 1996;31(3-4):137-148. (Pubitemid 26257964)
42. Hosmer DW, Lesmeshow, S. Applied logistic regression. 2nd ed. New York (NY): John Wiley & Sons, Inc; 2000.
43. Hanley JA, McNeil BJ. The meaning and use of the area under the receiver operating characteristic (ROC). Radiology. 1982;143:29-36.
44. Nagelkerle N. A note on general definition of the coeficient of determination. Biometrika. 1991;78:791-792.
45. Freeman DH. Applied categorical data analysis. New York (NY): Marcel Dekker Inc; 1987.
46. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983. (Pubitemid 41248376)
47. Barnes TR, Hutton SB, Chapman MJ, et al. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry. 2000;177:207-211.
48. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med. 2001;31(3):381-400.
49. Melle I, Haahr U, Friis S, et al. Reducing the duration of untreated first-episode psychosis - effects on baseline social functioning and quality of life. Acta Psychiatr Scand. 2005;112(6):469-473. (Pubitemid 41676692)
50. McGorry PD, Edwards J, Mihalopoulos C, et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326. (Pubitemid 26174576)
51. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7(3):148-156.
52. Malla AK, Norman RM, Manchanda R, et al. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med. 2002;32(6):1109-1119. (Pubitemid 34928301)
53. Joyce E, Hutton S, Mutsatsa S, et al. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl. 2002;43:S38-S44. (Pubitemid 34983511)
54. Lappin JM, Morgan KD, Morgan C, et al. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res. 2007;95(1-3):103-110. (Pubitemid 47313637)
55. Ho BC, Alicata D, Ward J, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry. 2003;160(1):142-148. (Pubitemid 36042438)
56. Rund BR, Melle I, Friis S, et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry. 2004;161(3):466-472. (Pubitemid 38326101)
57. Schmitz N, Malla A, Norman R, et al. Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity. Schizophr Res. 2007;93(1-3):152-159. (Pubitemid 46817957)
58. Buckley PF, Wirshing DA, Bhushan P, et al. Lack of insight in schizophrenia: impact on treatment adherence. CNS Drugs. 2007;21(2):129-141. (Pubitemid 46247818)
59. McGlashan TH, Levy ST, Carpenter WT Jr. Integration and sealing over. Clinically distinct recovery styles from schizophrenia. Arch Gen Psychiatry. 1975;32(10):1269-1272.